What does GALMART - BORREMANS do?

GALMART - BORREMANS is a pharmacy in Pajottegem. Private Limited, started on 8 September 1988, 1 establishment.

What is the address of GALMART - BORREMANS?

The registered office of GALMART - BORREMANS is located at Marktplein 5, 1570 Pajottegem.

Is GALMART - BORREMANS still active?

Yes. According to the CBE (31 October 2026) GALMART - BORREMANS is active, legal situation “Normale toestand”, started on 8 September 1988.

Is GALMART - BORREMANS registered on Peppol?

Yes, GALMART - BORREMANS is registered on the Peppol network with ID 0208:0435222370.

What is the enterprise number of GALMART - BORREMANS?

The enterprise number of GALMART - BORREMANS is BE0435222370.

When was GALMART - BORREMANS founded?

GALMART - BORREMANS was founded on 8 September 1988.

Who are the directors of GALMART - BORREMANS?

According to the 2025 annual accounts, the directors of GALMART - BORREMANS are: Bruno Galmart, Barbara Van Eylen.

Is GALMART - BORREMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 1988; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did GALMART - BORREMANS make in 2025?

GALMART - BORREMANS posted a profit after taxes of € 136,414 in financial year 2025.

What is the revenue of GALMART - BORREMANS?

As a small company, GALMART - BORREMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 470,823.

How much does an employee at GALMART - BORREMANS earn?

The average wage cost per full-time employee at GALMART - BORREMANS was € 79,700 in 2025: staff costs of € 278,808 for 3.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does GALMART - BORREMANS have?

According to the 2025 annual accounts, GALMART - BORREMANS has 3.5 full-time equivalents (FTE).

GALMART - BORREMANS (Private Limited) - Pajottegem

Dossier GALMART - BORREMANS, printed on 1 November 2026 from databakkes.be/en/0435222370/galmart-borremans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GALMART - BORREMANS from Pajottegem, company number BE0435222370, closed financial year 2025 with a result of € 136,414 after tax. For that financial year GALMART - BORREMANS recorded a gross margin of € 470,823 and equity of € 711,076. Compared with financial year 2024, the result moved from € 160,656 to € 136,414. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 711,076

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 136,414

▼ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 99,750

▼ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,000 paid out

95 % of the profit went to the shareholders, mostly to THE PHARMACY INVESTMENT COMPANY (80 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.5

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 278,808

▲ 9% vs 2024

€ 79,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 11,449

▼ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 201,032

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,331

▼ 43% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 347,030 Gross margin 2022: € 347,030 First fiscal year in the series	€ 415,305 Gross margin 2023: € 415,305 ▲ 20% vs 2022 (€ 347,030) Favourable step	€ 477,310 Gross margin 2024: € 477,310 ▲ 15% vs 2023 (€ 415,305) Favourable step	€ 470,823 Gross margin 2025: € 470,823 ▼ 1% vs 2024 (€ 477,310) Unfavourable step	▼ 1%
Profit after taxes	€ 144,359 Profit after taxes 2022: € 144,359 First fiscal year in the series	€ 130,752 Profit after taxes 2023: € 130,752 ▼ 9% vs 2022 (€ 144,359) Unfavourable step	€ 160,656 Profit after taxes 2024: € 160,656 ▲ 23% vs 2023 (€ 130,752) Favourable step	€ 136,414 Profit after taxes 2025: € 136,414 ▼ 15% vs 2024 (€ 160,656) Unfavourable step	▼ 15%
Equity	€ 673,254 Equity 2022: € 673,254 First fiscal year in the series	€ 684,006 Equity 2023: € 684,006 ▲ 2% vs 2022 (€ 673,254) Favourable step	€ 704,662 Equity 2024: € 704,662 ▲ 3% vs 2023 (€ 684,006) Favourable step	€ 711,076 Equity 2025: € 711,076 ▲ 1% vs 2024 (€ 704,662) Favourable step	▲ 1%
Total debts	€ 313,414 Total debts 2022: € 313,414 First fiscal year in the series	€ 381,694 Total debts 2023: € 381,694 ▲ 22% vs 2022 (€ 313,414) Unfavourable step	€ 452,715 Total debts 2024: € 452,715 ▲ 19% vs 2023 (€ 381,694) Unfavourable step	€ 451,240 Total debts 2025: € 451,240 Unchanged (€ 452,715) Favourable step
Cash	€ 90,060 Cash 2022: € 90,060 First fiscal year in the series	€ 111,675 Cash 2023: € 111,675 ▲ 24% vs 2022 (€ 90,060) Favourable step	€ 208,664 Cash 2024: € 208,664 ▲ 87% vs 2023 (€ 111,675) Favourable step	€ 99,750 Cash 2025: € 99,750 ▼ 52% vs 2024 (€ 208,664) Unfavourable step	▼ 52%
Land & buildings	€ 14,410 Land & buildings 2022: € 14,410 First fiscal year in the series	€ 12,926 Land & buildings 2023: € 12,926 ▼ 10% vs 2022 (€ 14,410) Unchanged	€ 23,547 Land & buildings 2024: € 23,547 ▲ 82% vs 2023 (€ 12,926) Unchanged	€ 24,888 Land & buildings 2025: € 24,888 ▲ 6% vs 2024 (€ 23,547) Unchanged	▲ 6%
Retained profit	€ 654,662 Retained profit 2022: € 654,662 First fiscal year in the series	€ 665,414 Retained profit 2023: € 665,414 ▲ 2% vs 2022 (€ 654,662) Favourable step	€ 686,070 Retained profit 2024: € 686,070 ▲ 3% vs 2023 (€ 665,414) Favourable step	€ 692,484 Retained profit 2025: € 692,484 ▲ 1% vs 2024 (€ 686,070) Favourable step	▲ 1%
Dividend	€ 140,000 Dividend 2022: € 140,000 First fiscal year in the series	€ 120,000 Dividend 2023: € 120,000 ▼ 14% vs 2022 (€ 140,000) Unchanged	€ 140,000 Dividend 2024: € 140,000 ▲ 17% vs 2023 (€ 120,000) Unchanged	€ 130,000 Dividend 2025: € 130,000 ▼ 7% vs 2024 (€ 140,000) Unchanged	▼ 7%
Balance sheet total	€ 986,668 Balance sheet total 2022: € 986,668 First fiscal year in the series	€ 1,065,700 Balance sheet total 2023: € 1,065,700 ▲ 8% vs 2022 (€ 986,668) Unchanged	€ 1,157,378 Balance sheet total 2024: € 1,157,378 ▲ 9% vs 2023 (€ 1,065,700) Unchanged	€ 1,162,316 Balance sheet total 2025: € 1,162,316 Unchanged (€ 1,157,378) Unchanged
Employees (FTE)	2.7 Employees (FTE) 2022: 2.7 First fiscal year in the series	3.4 Employees (FTE) 2023: 3.4 ▲ 0.7 vs 2022 (2.7) Unchanged	3.2 Employees (FTE) 2024: 3.2 ▼ 0.2 vs 2023 (3.4) Unchanged	3.5 Employees (FTE) 2025: 3.5 ▲ 0.3 vs 2024 (3.2) Unchanged	▲ 0.3

Key figures of GALMART - BORREMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GALMART - BORREMANS?

What happened at GALMART - BORREMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 136,414 (▼ 15% vs 2024). Source: NBB ↗
2001 Bruno Galmart became a director. NBB
Oct 28, 1988 New establishment in Pajottegem. KBO
Sep 8, 1988 Start of the company according to the CBE. KBO

In short

From € 144,359 profit in 2022 to € 136,414 profit in 2025.

Paid € 195,834 in corporate taxes since 2022.

Best year ever: 2024, with € 160,656 profit.

On average € 134,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

THE PHARMACY INVESTMENT COMPANY 80%

TRIBUTA RIVO 20%

The stake of THE PHARMACY INVESTMENT COMPANY, TRIBUTA RIVO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

GALMART - BORREMANS

Behind GALMART - BORREMANS are Bruno Galmart and Barbara Van Eylen. The shares are held by THE PHARMACY INVESTMENT COMPANY (80%) and TRIBUTA RIVO (20%).

Directors

According to the 2025 annual accounts

Bruno Galmart

Director

Also active at: APOTHEEK TOLLEMBEEK, THE PHARMACY INVESTMENT COMPANY, CASTORO

since 2001

Barbara Van Eylen

Director

Also active at: APOTHEEK TOLLEMBEEK, CASTORO, TRIBUTA RIVO

Shareholders

THE PHARMACY INVESTMENT COMPANY

80%

TRIBUTA RIVO

20%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marktplein 5

1570 Pajottegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

THE PHARMACY INVESTMENT COMPANY same network

€ 173,535 gross margin · 2025

APOTHEEK VOLLEZELE

€ 206,097 gross margin · 2025

CASTORO same network

€ 16,746 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0435.222.370

VAT number

BE 0435.222.370

Registered office

Marktplein 5, 1570 Pajottegem

Names & denominations

GALMART - BORREMANS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 September 1988

Peppol

Active · Active since 5 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

GALMART - BORREMANS

Financials

What happened to GALMART - BORREMANS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions